# Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/resmetirom-a-breakthrough-in-the-treatment-of-metabolic-dysfunction-associated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Laiba Shakeel,Ayesha Shaukat,Aymar Akilimali |
| Citations | 12 |
| DOI | 10.1002/hsr2.70920 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hsr2.70920 |
| OpenAlex ID | https://openalex.org/W4411431764 |
| PMID | 40535518 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Ayesha Shaukat](https://scholariq.org/researchers/ayesha-shaukat/)

## Paper journal

- [Health Science Reports](https://scholariq.org/journals/health-science-reports/)

## Paper primary topic

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Paper topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Drug-Induced Hepatotoxicity and Protection](https://scholariq.org/topics/drug-induced-hepatotoxicity-and-protection/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.